Publication

Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression

Journal Paper/Review - Nov 22, 2010

Units
PubMed
Doi

Citation
Bergthaler A, Flatz L, Hegazy A, Johnson S, Horvath E, Löhning M, Pinschewer D. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. Proc Natl Acad Sci USA 2010; 107:21641-6.
Type
Journal Paper/Review (English)
Journal
Proc Natl Acad Sci USA 2010; 107
Publication Date
Nov 22, 2010
Issn Electronic
1091-6490
Pages
21641-6
Brief description/objective

The Clone 13 (Cl13) strain of lymphocytic choriomeningitis virus is widely studied as a model of chronic systemic viral infection. Here, we used reverse genetic techniques to identify the molecular basis of Cl13 persistence and immunosuppression, the characteristics differentiating it from the closely related Armstrong strain. We found that a single-point mutation in the Cl13 polymerase was necessary and partially sufficient for viral persistence and immunosuppression. A glycoprotein mutation known to enhance dendritic cell targeting accentuated both characteristics but when introduced alone, failed to alter the phenotype of the Armstrong strain. The decisive polymerase mutation increased intracellular viral RNA load in plasmacytoid dendritic cells, which we identified as a main initial target cell type in vivo, and increased viremia in the early phase of infection. These findings establish the enhanced replicative capacity as the primary determinant of the Cl13 phenotype. Viral persistence and immunosuppression can, thus, represent a direct consequence of excessive viral replication overwhelming the host's antiviral defense.